share_log

Theriva Biologics Q3 EPS $(0.33) Beats $(0.39) Estimate

Theriva Biologics Q3 EPS $(0.33) Beats $(0.39) Estimate

Theriva Biologics第三季度每股收益(0.33)超过预期(0.39)
Benzinga Real-time News ·  2022/11/10 17:14

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 65 percent decrease over losses of $(0.20) per share from the same period last year.

Theriva Biologics(美国证券交易所股票代码:TOVX)公布季度每股亏损0.33美元,比分析师一致预期的每股亏损0.39美元高出15.38%。这比去年同期每股亏损0.20美元减少了65%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发